Tax selling should restrain any large run until after Jan 1, 2014. I'm hoping to perhaps buy one more chunk in the sub $4.80 range before Jan.
An advisory committee would likely work out quite well for MNKD as they would almost certainly vote for approval and in doing so cover the FDA's butt. While I have reservations about the company , I have nearly no doubt about a FDA approval and a positive adcom should Afrezza be assigned to one.
I hope your right about fabulous returns. I wonder if the studies you cite on needle aversion are asking pen users? Pen user's answers might be quite different . I know I have been quite surprised by the ease and convenience of an Insulin pen.
I do believe your correct about first time insulin users preference for a non injected solution. However, virtually all insulin users will be exposed to pen technology by the use of long term base insulin and some will find the near infinite dosage choices of pen technology appealing for use at mealtime.
I have no doubt Aferzza will find a place in the market.. There are numerous questions about it's level of acceptance and commercial success in the face of strong entrenched competition. My thought is that it will take noticeably longer than you expect. Not unlike the approval process, it will take longer and cost more.
As a user of the insulin pen, injections: ARE NO BIG DEAL. Without the pen injections are generally annoying. However, the pen technology makes it vastly easier and nearly painless. Afrezza, will find a market. But, not as easy or as swiftly as most posting here would have you believe. Temper your expectations.
While I do think there are profits to be made between now and April. SAFE HAVEN ! Really ? Please pull out a five yr. stock chart and a dictionary . Oh, and cutback on the scotch. I believe it is effecting the "IRRATIONAL EXUBERANCE " lobe of your cerebellum .
Anyway : after this modest language criticism .-- Good luck to us all !!
You believed Al Mann ! ? Very hazardous to your financial health ! None of Al's statements can be trusted unless you can interdependently verify them. Not so much as one single statement!
I might buy a little more, if tax selling gets the price below $4.50 here at the end of the year. I'll try and squeeze $8+ out, on or before mid April.
GNSZ phase 2 interm results in about 6-8 months (there seems to be a considerable survival benefit in cases of hepatic cancer.)- Low burn rate and big possible gains from this low price . There also seems to be a refreshing lack of arrogance on the part of management. With any sort of a break , you should be able to extract a reasonable profit.
OPC11 - Please drink the cool-aid! Everyone will be so much happier. They will be wrong, but they will be happier . Have a nice evening.
You might want to check your zero's . I'm pretty sure it was $ 3,000,000 not $ 3 billion. It might have been 30M but definitely NO billions involved.
A complete unsubstantiated PUMP from AL. He trotted this out in front of the most recent CRL and I think the first one also. The previous form was: a small country wanting to order $100,000,000. It didn't happen then either. It is a pump !!